Latest (most recent) oral direct thrombin inhibitor is -
Ans is 'c' i.e. Dabigatran o Ximelagatran was the first oral direct thrombin inhibitor approved; however, it was subsequently withdrawn from the market because of repos of liver failure. o Recently a new oral direct inhibitor, dabigatran, was approved for use in Europe for prevention of various thromboembolism in patients who have undergone hip or knee replacement surgery.
Ximelagatran
Indraparinux
Dabigatran
Fondaparinux
Dabigatran